FFFernanda Sarahí Fajardo-Espinoza

Fernanda Sarahí Fajardo-Espinoza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fernanda Sarahí Fajardo-Espinoza has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Marlid Cruz-Ramos

    Instituto Nacional de Cancerología Departamento de Oncología Médica de Mama ; Mexico City

    3 shared publications
  • Sara Aileen Cabrera-Nieto

    Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, Mexico

    3 shared publications
  • A Romero-Rojas

    Facultad de Estudios Superiores Cuautitlán Universidad Nacional Autónoma de México Carretera Cuautitlán-Teoloyucan Km. 2.5 CP 54714 Cuautitlán Izcalli México

    1 shared publication
  • Aimée C. Madariaga-Cobos

    Faculty of Health Sciences, Universidad Anahuac Mexico, Mexico

    1 shared publication
  • Alejandra Platas

    Physicians and Researchers in the Fight Against Breast Cancer, Centro Oncológico, Hospital Ángeles Acoxpa, Mexico City, Mexico

    1 shared publication
  • Alejandro Mohar

    Unidad de Epidemiología e Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, UNAM-Instituto Nacional de Cancerología, Mexico City, Mexico

    1 shared publication

Latest Publications

  • Challenges in implementing a multidisciplinary integrative oncology intervention for young women with localized breast cancer

    by Fernanda Sarahí Fajardo-Espinoza, Daniela Martínez-Palacios, Yanira E. Rodríguez-Fonseca, Dana Aline Pérez-Camargo, Carmen L. Gálvez-Hernández, Tavata Bejarano-Colina, Juan A. Torres-Domínguez, Ana Laura Rodríguez-Velázquez, Verónica Cedillo-Compeán, Rosa L. López-Bejarano, et al.


  • Open Access

    The Role of Adenosine in Overcoming Resistance in Sarcomas

    by Marlid Cruz-Ramos, Sara Aileen Cabrera-Nieto, Mario Murguia-Perez, Fernanda Sarahí Fajardo-Espinoza

    Resistance to systemic therapies in sarcomas poses a significant challenge to improving clinical outcomes. Recent research has concentrated on the tumor microenvironment’s role in sarcoma progression and treatment resistance. This microenvironment comprises a variety of cell types and signaling molecules that influence tumor behavior, including proliferation, metastasis, and resistance to therapy. Adenosine, abundant in the tumor microenvironment, has been implicated in promoting immunosuppression and chemoresistance. Targeting adenosine receptors and associated pathways offers a novel approach to enhancing immune responses against tumors, potentially improving immunotherapy outcomes in cancers, including sarcomas. Manipulating adenosine signaling also shows promise in overcoming chemotherapy resistance in these tumors. Clinical trials investigating adenosine receptor antagonists in sarcomas have fueled interest in this pathway for sarcoma treatment. Ultimately, a comprehensive understanding of the tumor and vascular microenvironments, as well as the adenosine pathway, may open new avenues for improving treatment outcomes and overcoming resistance in sarcoma. Further studies and clinical trials are crucial to validate these findings and optimize therapeutic strategies, particularly for osteosarcoma. This study provides a literature review exploring the potential role of the adenosine pathway in sarcomas.


  • Phase angle as a potential tool to evaluate chronic inflammatory state and predict quality of life deterioration in women with breast cancer and obesity: A narrative review

    by Fernanda Sarahí Fajardo-Espinoza, Sara Aileen Cabrera-Nieto, Ana Lorena Espada-Vargas, Dana Aline Pérez-Camargo, Alejandro Mohar, Marlid Cruz-Ramos


  • Open Access

    Effects of a high-protein diet and calcium caseinate supplementation on satiety perception and weight in Children with overweight and obesity: a randomized clinical trial

    by Fernanda Sarahí Fajardo-Espinoza, Karolina Alvarez-Altamirano, Alma Nubia Mendoza-Hernandez, Nayeli Garibay Nieto, Thamara Falcón-Álvarez, Mónica Bejarano Rosales, Anahí Raya-Hernández, Rubens Feferbaum, Vanessa Fuchs-Tarlovsky


  • In vitro cytomodulatory and immunomodulatory effects of bovine colostrum whey protein hydrolysates

    by Fernanda S. Fajardo‐Espinoza, Cynthia Ordaz‐Pichardo, Uma Sankar, Andrés Romero‐Rojas, Mario A. Moreno‐Eutimio, Humberto Hernández‐Sánchez

    Summary: Bovine colostrum possesses biological compounds involved in the development of the newborn. Among them, the proteins have drawn attention as a source of bioactive peptides. This study shows the in vitro cytotoxic and immunostimulatory potential of two colostrum whey protein (CWP) hydrolysates obtained by in vitro digestion with pepsin and pancreatin. MTT cell viability, apoptosis induction, polymorphonuclear proliferation and phagocytic activity assays were performed. Treatment with the hydrolysates induced a significant decrease in the viability of MDA‐MB‐231 cell lines due to apoptosis and also a significant increase in the proliferation of blood mononuclear cells. It could also be observed that for the RM‐1 and PC‐3 prostate cancer cell lines and for the two times of exposure (24 and 48 h), the hydrolysate H1 is significantly more cytotoxic than CWP. These results showed the potential of bovine CWP and its hydrolysates for the treatment of chronic diseases such as cancer.


  • Open Access

    PRODUCTION OF BIOACTIVE PEPTIDES FROM BOVINE COLOSTRUM WHEY USING ENZYMATIC HYDROLYSIS

    by F Fajardo-Espinoza, A Romero-Rojas, H Hernández-Sánchez

    Bovine colostrum is an important source of nutritional and immunological factors that are vital for the early development and protection of the newborn. The aim of this study was to evaluate the antioxidant, mineral-binding (iron and calcium), and angiotensin-converting enzyme (ACE) inhibitory properties of the peptides generated through the enzymatic hydrolysis of bovine colostrum whey proteins. The whey proteins were hydrolyzed with pepsin at two pH values (1.3 and 2), and in a sequential hydrolysis system with pepsin and pancreatin. The hydrolysates were separated by ultrafiltration in three fractions with molecular weights of less than 10, from 10 to 30, and more than 30 kDa. The antioxidant and calcium binding activities increased with the hydrolysis and the highest values were obtained in the case of the fractions with less than 10 kDa. The fractions with molecular weights higher than 30 kDa had the best iron binding capacity. A high positive correlation (R=0.9669) was obtained between the degree of hydrolysis and the ACE inhibitory activity. El calostro bovino es una importante fuente de factores inmunológicos y nutricionales que son vitales para el desarrollo y protección de la cría. En el presente estudio se prepararon hidrolizados de proteína de suero de calostro bovino usando pepsina a dos valores de pH (1.3 y 2) y también en hidrólisis secuencial con pancreatina. Los hidrolizados se separaron por ultrafiltración para obtener 3 fracciones de distintos pesos moleculares (>30kDa, 10-30 kDa y <10kDa) para ser analizadas como fuente de péptidos con actividad antioxidante, quelante de minerales (hierro y calcio) e inhibidora de la enzima convertidora de angiotensina (ECA). Se observó un aumento en la actividad antioxidante y quelante de calcio de los hidrolizados, principalmente en las fracciones de peso molecular 30kDa. Se observó una alta correlación positiva (R=0.9669) entre el grado de hidrólisis (mEq. Leucina) y la actividad inhibidora de la ECA.